Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Reset all filters
01 1Bachem Americas, Inc.
02 1Dr. Reddy's Laboratories Limited
03 1Fujian Genohope Biotech Ltd.
04 2Amphastar Nanjing Pharmaceuticals, Inc.
05 1Aurobindo Pharma Limited
06 1Biocon Limited
07 2Chengdu Shengnuo Biopharm Co. Ltd.
08 1DARMERICA, LLC
09 1ETERNAL WEALTH(CHINA)LIMITED
10 1FRESENIUS KABI IPSUM SRL
11 1Hubei JXBio Pharmaceutical Co., Ltd
12 4Hybio Pharmaceutical Co., Ltd.
13 11Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
14 1MSN Life Sciences Private Limited
15 1NOMIDA LLC
16 1Nanjing Cuccess Pharmaceutical Co., Ltd.
17 1Nanjing Hanxin Pharmaceutical Technology Co., Ltd.
18 1Nanjing Xingyin Pharmaceutical Group Co.,Ltd
19 1Novo Nordisk A/S
20 1Polypeptide Laboratories Inc
21 1Qingdao Biopeptek Co., Ltd.
22 1Qingdao Qinzeyuan Biotechnology Co., Ltd
23 1SUN PHARMACEUTICAL INDUSTRIES, INC.
24 1ScinoPharm Taiwan Ltd.
25 1Shanghai Ambiopharm, Inc
26 2Sinopep-Allsino Biopharmaceutical Co., Ltd.
27 1Tonghua Dongbao Pharmaceutical Co., Ltd
28 1Zhejiang Peptites Biotech Co., Ltd.
Reset all filters
01 2LIRAGLUTIDE
02 41Liraglutide
03 1liraglutide
Reset all filters
01 21China
02 1Denmark
03 4India
04 1Sweden
05 2Switzerland
06 1Taiwan
07 7U.S.A
08 7Blank
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 52416-735
Start Marketing Date : 2025-08-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-022
Start Marketing Date : 2020-06-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Fujian Genohope Biotech is a leading provider of high-potency peptide APIs, offering GMP quality and worldwide delivery.
NDC Package Code : 84502-104
Start Marketing Date : 2024-10-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14403-0009
Start Marketing Date : 2021-12-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14403-0009
Start Marketing Date : 2024-11-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14403-0009
Start Marketing Date : 2021-12-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14403-0009
Start Marketing Date : 2024-12-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14403-0009
Start Marketing Date : 2024-12-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14403-0009
Start Marketing Date : 2024-12-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 0420-9006
Start Marketing Date : 2011-02-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

27
PharmaCompass offers a list of Liraglutide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Liraglutide manufacturer or Liraglutide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Liraglutide manufacturer or Liraglutide supplier.
PharmaCompass also assists you with knowing the Liraglutide API Price utilized in the formulation of products. Liraglutide API Price is not always fixed or binding as the Liraglutide Price is obtained through a variety of data sources. The Liraglutide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Liraglutide Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Liraglutide Acetate, including repackagers and relabelers. The FDA regulates Liraglutide Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Liraglutide Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Liraglutide Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Liraglutide Acetate supplier is an individual or a company that provides Liraglutide Acetate active pharmaceutical ingredient (API) or Liraglutide Acetate finished formulations upon request. The Liraglutide Acetate suppliers may include Liraglutide Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Liraglutide Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Liraglutide Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Liraglutide Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Liraglutide Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Liraglutide Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Liraglutide Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Liraglutide Acetate suppliers with NDC on PharmaCompass.
We have 20 companies offering Liraglutide Acetate
Get in contact with the supplier of your choice: